Bank of Montreal
TNGX icon

Bank of Montreal’s Tango Therapeutics TNGX Stock Holding History

Bank of Montreal’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,494
Closed -$146K – 4025
2025
Q4 		$146K Buy
+16,494
New +$142K ﹤0.01% 2939
2022
Q3 		– Sell
-52,029
Closed -$231 – 4411
2022
Q2 		$231 Buy
+52,029
New +$315K ﹤0.01% 3185

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Bank of Montreal's TNGX Position: Q1 2026 in Review

Bank of Montreal sold out of Tango Therapeutics (TNGX) in Q1 2026, closing a stake of 16,494 shares — an estimated $146K sold.

Bank of Montreal first reported a position in TNGX in Q2 2022 and held it in 2 quarters. The position peaked at $146K in Q4 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Bank of Montreal reported no remaining Tango Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 16,494 Tango Therapeutics shares in Q1 2026, an estimated $146K.
  • Bank of Montreal first reported a position in Tango Therapeutics in Q2 2022 and held it in 2 quarters.
  • Bank of Montreal's Tango Therapeutics position peaked at $146K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.